From Name

From Email

To Name

To Email

Message

New ACC guidance on CVD risk reduction in diabetes

from Medscape

New ACC guidance on CVD risk reduction in diabetes Medscape A new expert consensus statement issued by the American College of Cardiology guides cardiologists in the initiation and monitoring of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to reduce cardiovascular disease risk in their patients with diabetes. READ MORE

more